Lytgobi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lytgobi, covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: EMA Authorised: Lytgobi (Futibatinib) — Taiho Pharma Netherlands B.V.
1 regulatory and trial event tracked for Lytgobi, covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: EMA Authorised: Lytgobi (Futibatinib) — Taiho Pharma Netherlands B.V.